Foreign-body reaction to the Artelon CMC joint spacer: case report.
The Artelon CMC spacer (Small Bone Innovations, Inc., Morrisville, PA) is a relatively new device that was developed for the treatment of basal joint arthritis. It is composed of a biodegradable polycaprolactone-based polyurethane urea that acts to resurface the distal part of the trapezium and stabilize the trapeziometacarpal joint by augmenting the joint capsule. This is a case report of a foreign-body tissue reaction to the Artelon CMC spacer.
Choung
Edward W
EW
Department of Orthopaedics, University of Medicine and Dentistry of New Jersey, New Jersey Medical School/University Hospital, Newark, NJ 07103, USA.
Tan
Virak
V
D020341:Absorbable Implants / Q000009:adverse effects*; D052737:Carpometacarpal Joints / Q000503:physiopathology / Q000601:surgery; D002908:Chronic Disease; D005260:Female; D005549:Foreign-Body Reaction / Q000209:etiology*; D006801:Humans; D017746:Joint Capsule / Q000601:surgery; D007595:Joint Prosthesis / Q000009:adverse effects*; D008875:Middle Aged; D010003:Osteoarthritis / Q000503:physiopathology / Q000601:surgery; D011091:Polyesters / Q000009:adverse effects; D011140:Polyurethanes / Q000009:adverse effects; D013585:Synovitis / Q000209:etiology*; D051222:Trapezium Bone / Q000601:surgery
D011091:Polyesters; D011140:Polyurethanes; C016240:polycaprolactone